1. Home
  2. CIM vs CDNA Comparison

CIM vs CDNA Comparison

Compare CIM & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$12.87

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.47

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIM
CDNA
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
712.2M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
CIM
CDNA
Price
$12.87
$19.47
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$15.25
$26.67
AVG Volume (30 Days)
771.2K
782.3K
Earning Date
02-11-2026
11-04-2025
Dividend Yield
11.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$191,573,000.00
$357,998,000.00
Revenue This Year
$11.44
$14.11
Revenue Next Year
$21.50
$11.75
P/E Ratio
N/A
$16.24
Revenue Growth
N/A
14.46
52 Week Low
$9.85
$10.96
52 Week High
$15.37
$25.95

Technical Indicators

Market Signals
Indicator
CIM
CDNA
Relative Strength Index (RSI) 52.90 58.23
Support Level $12.73 $19.01
Resistance Level $13.04 $20.61
Average True Range (ATR) 0.24 0.80
MACD 0.01 -0.11
Stochastic Oscillator 63.47 45.12

Price Performance

Historical Comparison
CIM
CDNA

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: